• Blog
  • Equity Research
    • Sector Rotation
    • Stock Wise Rotation
    • Case Study
    • Shareholding
    • Blockbuster Quarterly Result
  • Market Weekly
  • IPO Analysis
  • About
What's New!

Ather Energy Limited | IPO Analysis

28 April 2025

Laxmi Dental Limited | IPO Analysis

13 January 2025

Quadrant Future Tek Limited | IPO Analysis

7 January 2025
Facebook Instagram YouTube LinkedIn
Facebook Instagram YouTube LinkedIn
InwealfoneyInwealfoney
  • Blog
  • Equity Research
    • Sector Rotation
    • Stock Wise Rotation
    • Case Study
    • Shareholding
    • Blockbuster Quarterly Result
  • Market Weekly
  • IPO Analysis
  • About
InwealfoneyInwealfoney
Home»Blog»Concord Biotech Limited | IPO Analysis
Blog

Concord Biotech Limited | IPO Analysis

Vicky NagarBy Vicky Nagar12 August 2023Updated:12 August 2023No Comments2 Mins Read
Share
Facebook Twitter LinkedIn WhatsApp

About the Company:

• Concord Biotech Limited is an R&D-driven biopharma company based in India, established in 1984. It holds a prominent position globally as a developer and manufacturer of fermentation-based APIs, particularly in immunosuppressants and oncology, leading in market share by volume in 2022.

• With a strong international presence, Concord supplies its products to more than 70 countries, including the USA, India, Europe, and Japan.

• The company specializes in manufacturing Active Pharmaceutical Ingredients (API) using fermentation and semi-synthetic processes, expanding from a single product to a comprehensive solution provider.

• Concord's product range covers therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals, and more, attracting customers worldwide. Additionally, the company boasts a robust pipeline of products currently under development.

Financials and Valuation:

The following table shows the summary of financials for the latest three financial years along with CAGR return from FY21 to FY23.

Next, we compare the key valuation ratios with the listed peers of SBFC Finance Limited.

Based on the financials of FY23 and the upper price band of the IPO, we can calculate the relative valuation as mentioned in the below table:

Conclusion:

1) Apart from the Price to Earnings Ratio, the valuation of Concord Biotech Limited appears justified for long-term investment based on the other three criteria.

2) Though the IPO is fully priced, as per the latest GMP, a small listing gain in the range of 15% to 20%, can be expected subject to the overall market conditions.

Note: For additional information & risk factors please refer to the Red Herring Prospectus

Disclaimer: We are not SEBI registered. All the views are personal and only for educational purposes. Do your due diligence before making any trading or investing decision. The data provided in this blog post is for illustrative purposes only and does not constitute financial advice. Always consult with a qualified financial advisor before making investment decisions.

Read the detailed ‘Disclaimer’ here.

Share. Facebook Twitter LinkedIn WhatsApp
Previous ArticleSBFC Finance Limited | IPO Analysis
Next Article Market Weekly: 7th to 11th Aug, 2023
Vicky Nagar
  • Website

Vicky Nagar is an equity trader with 5+ years of experience in trading and investing. He has expertise in equity valuation, sectoral analysis, index analysis, and in identifying the market trends. He is a NISM Certified Research Analyst. Formerly a relationship manager at Kotak Mahindra Bank Limited in the Agri-Business Group, he also has teaching experience at KS School of Business Management, Gujarat University, and as an Academic Associate at IRMA (Institute of Rural Management Anand). He holds a BBA (Gold Medalist) and an MBA (Gold Medalist) in Marketing.

Related Posts

28 April 2025

Ather Energy Limited | IPO Analysis

28 April 2025By Vicky Nagar
Read More
13 January 2025

Laxmi Dental Limited | IPO Analysis

13 January 2025By Vicky Nagar
Read More
7 January 2025

Quadrant Future Tek Limited | IPO Analysis

7 January 2025By Vicky Nagar
Read More

Leave A Reply Cancel Reply

Top Posts
© 2025 Inwealfoney. All rights reserved..

Type above and press Enter to search. Press Esc to cancel.